"We are very encouraged by the wide distribution Erchonia Europe has been able to secure for Zerona and are looking forward to launching other Erchonia products in the European market," says Charlie Shanks, vice president of Erchonia.

Zerona is the only device on the market proven effective with a

double blind, multi-site, placebo-controlled study, and is the only non-invasive procedure that guarantees an average of three inches lost in as little as two weeks.

The Zerona protocol consists of six, painless treatments; one forty-minute treatment every other day for two weeks. Erchonia's Zerona laser produces a low-level output that has no thermal effect on the body's tissue and, unlike the majority of other devices on the market, its unique technology does not kill or damage fat cells. Zerona instead creates a pore in each cell for the fat to leak out. The fat is then processed naturally through the lymphatic system, leaving the cell intact.